Bowman & CO S.C. Iqvia Holdings Inc. Transaction History

Bowman & CO S.C.

$187 Million
Q3 2024

A detailed history of Bowman & CO S.C. transactions in Iqvia Holdings Inc. stock. As of the latest transaction made, Bowman & CO S.C. holds 5,403 shares of IQV stock, worth $1.07 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

5,403

Previous 4,852 11.36%

Holding current value

$1.07 Million

Previous $1.03 Million 24.78%

% of portfolio

0.68%

Previous 0.6%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$206.81 - $251.55 $113,952 - $138,604	551 Added 11.36%	5,403 $1.28 Million
Q2 2024 Jul 24, 2024	BUY	$211.18 - $248.87 $85,950 - $101,290	407 Added 9.16%	4,852 $1.03 Million
Q1 2024 Apr 15, 2024	SELL	$208.23 - $259.1 $2,498 - $3,109	-12 Reduced 0.27%	4,445 $1.12 Million
Q4 2023 Jan 10, 2024	BUY	$177.16 - $232.73 $50,667 - $66,560	286 Added 6.86%	4,457 $1.03 Million
Q3 2023 Oct 04, 2023	BUY	$196.75 - $231.96 $159,957 - $188,583	813 Added 24.21%	4,171 $820,000
Q2 2023 Jul 17, 2023	BUY	$183.66 - $224.77 $14,509 - $17,756	79 Added 2.41%	3,358 $754,000
Q1 2023 Apr 13, 2023	BUY	$188.0 - $240.65 $58,468 - $74,842	311 Added 10.48%	3,279 $652,000
Q4 2022 Jan 20, 2023	BUY	$172.45 - $226.53 $48,458 - $63,654	281 Added 10.46%	2,968 $0
Q3 2022 Nov 14, 2022	BUY	$181.14 - $248.26 $15,215 - $20,853	84 Added 3.23%	2,687 $487,000
Q2 2022 Jul 29, 2022	BUY	$196.45 - $252.29 $28,288 - $36,329	144 Added 5.86%	2,603 $565,000
Q1 2022 Apr 29, 2022	BUY	$210.56 - $273.58 $21,266 - $27,631	101 Added 4.28%	2,459 $569,000
Q4 2021 Jan 31, 2022	BUY	$238.37 - $282.61 $562,076 - $666,394	2,358 New	2,358 $663,000

Others Institutions Holding IQV

# of Institutions

1,140

Shares Held

142M

Call Options Held

828K

Put Options Held

951K

View Full List

About IQVIA HOLDINGS INC.

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $36.7B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

More about IQV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowman & CO S.C., based on Form 13F filings with the SEC.

News

Stay updated on Bowman & CO S.C. with notifications on news.

Account